Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001218

CERILLIANT™ 10,11-Dihydro-10-Hydroxycarbamazepine-13C6 Solution, 100 μg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™

Catalog No. 01001218 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-218 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-218 Supplier MilliporeSigma Supelco Supplier No. D1041ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

Also known as monohydroxy carbamazepine (MHC), 10,11-Dihydro-10-Hydroxycarbamazepine is a pharmacologically active, primary metabolite of oxcarbazepine in urine. Oxcarbazepine, sold under the trade name Trileptal™, is an antiepileptic drug used for the treatment of epilepsy and mood disorders. This stable-labeled internal standard is suitable for quantitation of MHC levels in urine, serum, or plasma by LC/MS or GC/MS for pain prescription monitoring, clinical toxicology, therapeutic drug monitoring or urine drug testing applications.
TRUSTED_SUSTAINABILITY

Specifications

CAS 75-05-8
Linear Formula 13C6C9H14N2O2
UN Number UN 1648 3 / PGII
Concentration 100 μg/mL in acetonitrile
Formula Weight 260.24
Packaging Ampule
Quantity 1 mL
Flash Point 2°C (35.6°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.